 | |
| Clinical data | |
|---|---|
| Other names | Estr-5-ene-3β,17β-diol; 19-Norandrost-5-ene-3β,17β-diol |
| Routes of administration | By mouth |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C18H28O2 |
| Molar mass | 276.420 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
19-Nor-5-androstenediol, also known asestr-5-ene-3β,17β-diol, is asynthetic,orally activeanabolic-androgenic steroid (AAS) and aderivative of19-nortestosterone (nandrolone) that was never introduced formedical use.[1][2][3] It is anandrogen prohormone ofnandrolone and of other19-norandrostanes.[1][2][3]
19-Nor-5-androstenediol,19-nor-5-androstenedione, and other 19-norandrostane prohormones were considered to benutritional supplements and were soldover-the-counter in theUnited States as a result of theDietary Supplement Health and Education Act of 1994 (DSHEA).[1][2] However, they were banned from sports in 1999 by theInternational Olympic Committee (IOC) and are currently on theWorld Anti-Doping Agency (WADA) list of prohibited substances.[1] In 2004, they becamecontrolled substances in the U.S. as a result of theAnabolic Steroid Control Act of 2004.[1]
 | Thisdrug article relating to thegenito-urinary system is astub. You can help Wikipedia byexpanding it. |
